Document details

In vivo requirement of the small subunit of U2AF for recognition of a weak 3′ splice site

Author(s): Pacheco, Teresa ; Coelho, Miguel B. ; Desterro, Joana ; Mollet, Inês G. ; Carmo-Fonseca, Maria

Date: 2006

Persistent ID: http://hdl.handle.net/10451/47831

Origin: Repositório da Universidade de Lisboa

Project/scholarship: info:eu-repo/grantAgreement/FCT/POCI/POCI%2FSAU-MMO%2F57700%2F2004/PT; info:eu-repo/grantAgreement/FCT/POCTI/PRAXIS XXI%2FBD%2F18044%2F98/PT;


Description

Copyright © 2006, American Society for Microbiology. All Rights Reserved.

The U2 snRNP auxiliary factor (U2AF) is an essential splicing factor composed of two subunits, a large, 65-kDa subunit (U2AF(65)) and a small subunit, U2AF(35). U2AF(65) binds to the polypyrimidine tract upstream from the 3' splice site and promotes U2 snRNP binding to the pre-mRNA. Based on in vitro studies, it has been proposed that U2AF(35) plays a role in assisting U2AF(65) recruitment to nonconsensus polypyrimidine tracts. Here we have analyzed in vivo the roles of the two subunits of U2AF in the selection between alternative 3' splice sites associated with polypyrimidine tracts of different strengths. Our results reveal a feedback mechanism by which RNA interference (RNAi)-mediated depletion of U2AF(65) triggers the downregulation of U2AF(35). We further show that the knockdown of each U2AF subunit inhibits weak 3' splice site recognition, while overexpression of U2AF(65) alone is sufficient to activate the selection of this splice site. A variant of U2AF(65) lacking the interaction domain with U2AF(35) shows a reduced ability to promote this splicing event, suggesting that recognition of the weak 3' splice site involves the U2AF heterodimer. Furthermore, our data suggest that, rather than being required for splicing of all pre-mRNA substrates containing a weak polypyrimidine tract, U2AF(35) regulates the selection of weak 3' splice sites in a specific subset of cellular transcripts.

This work was supported by grants from Fundação para a Ciência e Tecnologia, Portugal (POCI/SAU-MMO/57700/2004), the Human Frontier Science Program Organization (RG0300/2000-M), and the European Commission (EURASNET). T. R. Pacheco was supported by an FCT fellowship (PRAXIS XXI/BD/18044/98).

Document Type Journal article
Language English
Contributor(s) Repositório da Universidade de Lisboa
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents

No related documents